Cases 11 - 20 of 404
Novartis Pharmaceuticals Corporation v. Mylan Pharmaceuticals Inc.
as 23-2260
Plaintiff / Appellant:
NOVARTIS PHARMACEUTICALS CORPORATION
Defendant / Appellee:
MYLAN PHARMACEUTICALS INC.
In Re: Xarelto (Rivaroxaban) ('310) Patent Litigation
as 1:2021md03017
In Re:
Xarelto (Rivaroxaban) ('310) Patent Litigation
Not Classified By Court:
Clerk of MDL Panel, Lupin Limited, Lupin Pharmaceuticals, Inc. and others
Counter Defendant:
Bayer Pharma AG, Bayer AG and Janssen Pharmaceuticals, Inc.
Defendant:
ScieGen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Mylan Pharmaceuticals Inc. v. Bayer Intellectual Property GMBH et al
as 1:2023cv00556
Plaintiff:
Mylan Pharmaceuticals Inc.
Defendant:
Bayer Intellectual Property GMBH, Bayer AG and Janssen Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
Abraxis Bioscience, LLC v. Mylan Pharmaceuticals, Inc.
as 1:2023cv00033
Counter Defendant:
Abraxis Bioscience, LLC
Defendant:
Mylan Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
In Re: Ozempic (Semaglutide) Patent Litigation
as 1:2022md03038
Not Classified By Court:
Zydus Lifesciences Limited, Ozempic (Semaglutide) Patent Litigation, Novo Nordisk Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Novo Nordisk Inc. et al v. Viatris Inc. et al
as 1:2023cv00101
Plaintiff:
Novo Nordisk Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB v. Mylan Pharmaceuticals Inc.
as 23-1267
Plaintiff / Appellee:
ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP
Defendant / Appellant:
MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P.
Novo Nordisk, Inc. et al v. Viatris Inc. et al
as 1:2023cv00013
Plaintiff:
Novo Nordisk, Inc. and Novo Nordisk A/S
Defendant:
Viatris Inc. and Mylan Pharmaceuticals Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
AstraZeneca AB v. Mylan Pharmaceuticals Inc.
as 23-1164
Plaintiff / Appellant:
ASTRAZENECA AB and ASTRAZENECA PHARMACEUTICALS LP
Defendant / Appellee:
MYLAN PHARMACEUTICALS INC. and KINDEVA DRUG DELIVERY L.P.
Novartis Pharmaceuticals Corporation v. Alembic Pharmaceuticals Limited et al
as 1:2022cv01395
Plaintiff:
Novartis Pharmaceuticals Corporation
Defendant:
Alembic Pharmaceuticals Limited, Alembic Global Holding SA, Alembic Pharmaceuticals, Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
